Webinars

The webinar covers:

• Learn the type of evidence health systems value analysis leaders are looking for to drive centralized decision-making
• Hear examples of data that is most compelling to value analysis teams
• Uncover how you can create partnerships to generate evidence that results in differentiated product selection

Speaker: Jannet M. Carmichael, BS, Pharm.D., BCPS, FCCP, FAPhA

In this webinar, Amplity’s VA practice lead and former VA VISN Pharmacy Executive, Jannet Carmichael, PharmD, reviews strategies to achieve meaningful awareness and adoption in today’s complex VA landscape. Highlights of this session include how to successfully navigate new access limitations and reframe your organization’s understanding of current VA market dynamics.

Speakers: Joe Turner and Parris Abney

Whether you’re planning your launch messaging, optimizing your current messaging, educating patients, or simply interested in discontinuation drivers, it’s critical that you have a sense for what the variables are that impact HCP treatment decision surrounding discontinuation. In this on-demand webinar, our data experts will take you through the insights derived from the Discontinuation Report.

Speakers: Cheryl Nagowski and Dan Cusack

Amplity Health is hosting a three-part webinar series on the trends and challenges surrounding market access. In the second in this webinar series, Cheryl Nagowski and Dan Cusack walk participants through the current thinking around payer price sensitivities. This session explores why manufacturers are beginning to roll the dice with their pre-commercial assets and step away from the payer table. Watch now for our experts’ take on this new market access paradigm as you prepare your commercialization strategy for 2022 and beyond.

Speakers: Frank Arena and Rich Keenan

Amplity Health is hosting a three-part webinar series on the trends and challenges surrounding patient access to recently approved specialty products in 2022 and beyond. Watch the first in this webinar series to learn about the business case for adding a Field Reimbursement Manager (FRM) team at time of launch to support your Market Access strategy; the differences between an FRM “buy and bill” supporting team vs. an FRM “specialty pharmacy” team; and how to coordinate efforts between Payor Account Directors, Sales, Marketing, the HUB and Field Reimbursement Managers.

Speakers: Dawn Lacallade, Chief of Social Strategy, VP, Healthcare, LiveWorld and Danny Flamberg, VP Strategy, HCP, LiveWorld

Consumer’s growing affinity for digital, mobile, video, and social media has changed the healthcare landscape permanently. As we’ve seen in prior technology-driven shifts in behavior, there is no going back. Register to learn how pharma brands can leverage the patient need for connection and information, using the newest tools and tactics to influence patients and boost demand. Join us to discover:

• A new model of patient interaction and engagement
• Proven tools and tactics that motivate participation in brand programs
• Processes to remove risk from online programs
• Untapped value of patient-to-patient conversations
• Tips on increasing digital marketing KPIs and ROI

Ensure a Fast, Seamless Virtual Product Launch: Pharma Marketer’s Guide to Success in a Hybrid World

It’s a harsh reality that over half of all sellers miss their quota in an average year—and this year has been anything but average. With the uncertainty of the pandemic, many companies are hybrid. Workforces are remote, in-person connectivity is hard to come by, and the world continues to change at breakneck speed.

How big patient-centric data can be queried for answers in minutes versus months

Understanding the patient journey — from symptoms, to diagnosis, and treatment — is a standard and essential part of a life science company’s business practice. The information gleaned assists in patient and physician segmentation, forecasting, and building a marketing plan for upcoming and newly launched products, and is often updated annually to see if the journey has changed.

SPEAKER: Daniel Schwartz, MD, FRCPC
Daniel Schwartz, MD is career medical educator and founder of QxMD

Optimizing the Modern Disease State Awareness Campaign

Topic Overview:

Generating top-of-mind awareness is a key challenge in diagnosing both rare and non-rare diseases that otherwise could be missed. Creating that awareness is one of the biggest challenges for pharmaceutical marketers.

Join this webcast to explore the modern disease state awareness campaign and how innovative platforms can help you bring your information closer to the point of care, all from the perspective of a practicing clinician.

Key Learning Objectives:

• Review why disease state awareness is important, both for rare disease and more common disease states
• Identify surmountable challenges in disease awareness
• Learn 5 new tools to improve the success of your next disease state awareness campaign
• Incorporate innovative digital platforms in your campaign strategy

SPEAKER: Tom Kottler
Co-founder and CEO
HealthPrize Technologies

Despite common beliefs, nonadherence is not a matter of cost or forgetfulness, but human psychology. Even if you were to give medications away for free you may barely make a dent in the adherence problem, but by using psychological motivators like gamification and behavioral economics you can significantly improve adherence by creating a higher value of the act of taking medications. Register for this webinar to learn these tactics to improve adherence, reduce gap days without medication, and even re-acquire patients who stopped taking their medications.

FIND OUT IN THIS WEBINAR REPLAY why the use of psychological motivators like gamification and behavioral economics are so successful in improving adherence. YOU WILL LEARN:

• WHY the use of psychological motivators like gamification and behavioral economics are so successful in improving adherence.
• HOW to use these tactics to create digital experiences that frequently and consistently engage and educate patients.
• HOW patient adherence programs based on these motivators can create new revenue for your brands.

Distributing promotional materials in today’s multichannel, digital world brings new challenges in maintaining compliance and consistency of message. Demands for access to the latest content across multiple channels requires an end-to-end content management and distribution solution for promotional materials that is seamless, efficient, and compliant.

Watch this 10-minute webinar to learn how to:

• Increase process efficiency during content creation and approvals
• Enable multichannel content distribution
• Maintain compliance beyond distribution
• Gain actionable insight into the end-to-end process

New Patient Adherence Data:
Unlock New Sources for the Adherence Data Payers Want
Learn About New Tools for Building Brands and Loyalty

The expectation for pharmaceutical manufacturers is changing along the healthcare continuum as more is expected out of them than ever before. But new sources of data are now available through which companies can gain the adherence insights necessary to help them to improve relationships with providers, patients and payers—and increase their top lines. PM360 hosted this exclusive webcast, sponsored by Sharps Compliance, to discuss how leveraging new sources of data enables companies to better guide patient education and communications efforts, demonstrate their commitment to improving outcomes and discover new methods for increasing adherence. Information from case studies reveals how this data will lead to improved adherence and higher revenue, increased prescriptions for your brand, and more trusting relationships between providers, patients, payers and pharmaceutical manufacturers.

Brandon Beaver
Senior Vice President of Sales
Manages relationships with current Sharps Patient Support Program pharmaceutical clients, including program development.

David Tusa
President and CEO
Oversees all aspects of Sharps Compliance business.

Gregory C. Davis
Vice President of Operations
Manages Sharps Patient Support Program logistics, program system builds, reporting design, and interfacing.

Dennis P. Halligan

Vice President of Marketing
Manages Sharps Patient Support System program reviews and therapy-specific branding.

The patient engagement model is shifting. Historically, the relationship between drug developers and patients is often viewed in commercial terms. Recently, there has been chatter of pharma, patients, and advocacy uniting to harness patient and advocacy insights and build lasting relationships. This PM360 Webcast will probe this dynamic alliance and delve into the issues that ignited the broadening dialogue and discuss the growing importance of collaborating from the onset of development to post-approval.

Hosted by Paul Kidwell and Featuring:

Thomas P. Sellers, MPA
Sr. Director, Patient Advocacy & Corporate Philanthropy
Takeda Oncology

Tom Sellers is a cancer survivor. He joined Millennium in 2011 and currently manages relationships with the patient community and programs ensuring patients have information and access to treatments.

Ronny Mosston
Vice President of Patient Advocacy & Public Affairs
OvaScience

Ronny currently works for a company focused on the discovery, development,and commercialization of new fertility treatments. She has consulted biotech organizations to develop innovative, compliant, and cross-functional PatientAdvocacy strategies in all phases of the drug pipeline.

Brenda Snow
Founder & CEO
The Snow Companies

Ms. Snow is living with multiple sclerosis and has made it her life’s mission to connect people living with chronic conditions to their peers and leaders in the life science industry. As the Founder and CEO of the healthcare communication agency The Snow Companies, she is making this vision a reality.